Lineage Cell Therapeutics Inc (LCTX) — Financial Flexibility Index
Lineage Cell Therapeutics Inc (LCTX) has a Financial Flexibility Index of -0.05x as of September 2025. Free cash flow of $-3.60 Million (operating CF $-3.62 Million minus capex $12.00K) represents 0% of total liabilities ($68.84 Million). Check how aggressively does Lineage Cell Therapeutics Inc reinvest cash to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Lineage Cell Therapeutics Inc Financial Flexibility Index (1991–2024)
Historical Financial Flexibility Index trend for Lineage Cell Therapeutics Inc across 34 annual periods. For the full cash flow conversion analysis, see Lineage Cell Therapeutics Inc operating cash flow efficiency.
Annual Financial Flexibility Index for Lineage Cell Therapeutics Inc (1991–2024)
Year-by-year free cash flow to debt coverage for Lineage Cell Therapeutics Inc. Explore LCTX operating cash flow to total debt to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -0.62x | $-22.53 Million | $-23.09 Million | $36.21 Million | ▲ +13.0% |
| 2023 | -0.72x | $-27.89 Million | $-28.57 Million | $39.00 Million | ▼ -2613.5% |
| 2022 | 0.03x | $1.47 Million | $1.06 Million | $51.73 Million | ▲ +110.3% |
| 2021 | -0.28x | $-23.21 Million | $-23.56 Million | $83.65 Million | ▲ +81.9% |
| 2020 | -1.54x | $-19.69 Million | $-19.75 Million | $12.82 Million | ▲ +30.6% |
| 2019 | -2.21x | $-31.51 Million | $-31.95 Million | $14.23 Million | ▲ +24.5% |
| 2018 | -2.93x | $-27.59 Million | $-30.88 Million | $9.41 Million | ▲ +9.8% |
| 2017 | -3.25x | $-29.19 Million | $-30.52 Million | $8.98 Million | ▲ +1.4% |
| 2016 | -3.30x | $-39.80 Million | $-42.33 Million | $12.06 Million | ▼ -53.2% |
| 2015 | -2.15x | $-39.21 Million | $-44.54 Million | $18.21 Million | ▲ +31.7% |
| 2014 | -3.15x | $-38.37 Million | $-38.85 Million | $12.18 Million | ▼ -79.0% |
| 2013 | -1.76x | $-27.23 Million | $-29.51 Million | $15.47 Million | ▲ +50.2% |
| 2012 | -3.53x | $-19.28 Million | $-19.68 Million | $5.45 Million | ▼ -22.3% |
| 2011 | -2.89x | $-12.63 Million | $-13.59 Million | $4.37 Million | ▼ -52.3% |
| 2010 | -1.90x | $-7.30 Million | $-7.73 Million | $3.85 Million | ▼ -7.8% |
| 2009 | -1.76x | $-4.20 Million | $-4.26 Million | $2.39 Million | ▼ -1172.3% |
| 2008 | -0.14x | $-744.37K | $-1.60 Million | $5.38 Million | ▲ +63.9% |
| 2007 | -0.38x | $-1.23 Million | $-1.24 Million | $3.22 Million | ▲ +23.0% |
| 2006 | -0.50x | $-1.25 Million | $-1.26 Million | $2.52 Million | ▲ +24.2% |
| 2005 | -0.66x | $-1.41 Million | $-1.41 Million | $2.16 Million | ▲ +49.8% |
| 2004 | -1.31x | $-1.54 Million | $-1.54 Million | $1.18 Million | ▼ -599.1% |
| 2003 | -0.19x | $-654.14K | $-654.14K | $3.50 Million | ▲ +76.6% |
| 2002 | -0.80x | $-2.13 Million | $-2.13 Million | $2.67 Million | ▲ +49.3% |
| 2001 | -1.57x | $-3.20 Million | $-3.21 Million | $2.04 Million | ▲ +88.3% |
| 2000 | -13.41x | $-4.82 Million | $-4.86 Million | $359.75K | ▼ -88.6% |
| 1999 | -7.11x | $-4.23 Million | $-4.39 Million | $595.51K | ▼ -42.2% |
| 1998 | -5.00x | $-2.00 Million | $-2.10 Million | $400.00K | ▼ -650.0% |
| 1997 | -0.67x | $-1.20 Million | $-1.30 Million | $1.80 Million | ▲ +93.7% |
| 1996 | -10.50x | $-2.10 Million | $-2.10 Million | $200.00K | ▲ +0.0% |
| 1995 | -10.50x | $-2.10 Million | $-2.10 Million | $200.00K | ▼ -121.1% |
| 1994 | -4.75x | $-1.90 Million | $-2.00 Million | $400.00K | ▲ +70.3% |
| 1993 | -16.00x | $-1.60 Million | $-1.60 Million | $100.00K | ▼ -23.1% |
| 1992 | -13.00x | $-1.30 Million | $-1.30 Million | $100.00K | ▼ -333.3% |
| 1991 | -3.00x | $-600.00K | $-600.00K | $200.00K | — |